Action GeneThera (CE) - GTHR

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,0001

Prix Achat

0,00

Prix Vente

0,00

Volume échangé

0,00 Fourchette du Jour 0,00

0,000001 Plage de 52 semaines 0,0001

Clôture Veille

0,0001

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Applied Genetics Initiates Commercial Operation

Applied Genetics Initiates Commercial Operation PR Newswire WESTMINSTER, Colo., June 25, 2012 WESTMINSTER, Colo., June 25, 2012 /PRNewswire/...

Applied Genetics Signs Agreement With The National University Of Mexico (UNAM)

Applied Genetics Signs Agreement With The National University Of Mexico (UNAM) PR Newswire WESTMINSTER, Colo., May 16, 2012 WESTMINSTER, Colo...

Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada

Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada PR Newswire WESTMINSTER, Colo., Feb. 22, 2012 WESTMINSTER...

GeneThera, Inc. Acquires Applied Genetics, S.A.

GeneThera, Inc. Acquires Applied Genetics, S.A. PR Newswire WESTMINSTER, Colo., Jan. 25, 2012 WESTMINSTER, Colo., Jan. 25, 2012 /PRNewswire/...

GeneThera Extends its Reach Overseas

Results from Pharma Finance 2009 ARVADA, Colo., June 16 /PRNewswire-FirstCall/ -- GeneThera, Inc. (OTC: GTHR.PK). GeneThera, as a service and...

[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR

NEW YORK, Nov. 25 /PRNewswire-FirstCall/ -- Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino...

GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.

WHEAT RIDGE, Colo., Nov. 24 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR.PK), announces it will soon begin offering its Real...

GeneThera Releases Results From Initial Animal Tests of E.Coli O157:h7 Vaccine Amid News of Increase of E.Coli Discoveries in Be

WHEAT RIDGE, Colo., Nov. 17 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), today released information about its E.Coli O157:H7...

[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR

NEW YORK, Nov. 4 /PRNewswire-FirstCall/ -- Wall St. Network's 3-Minute Press Show is a daily program hosted by WSN reporter Tracee Tolentino...

GeneThera - CHANGING DIRECTIONS - an Update to Shareholders

WHEAT RIDGE, Colo., Nov. 3 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), As a service and responsibility to our shareholders...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0.0001	0.0001	0.0001	0	0	CS
52	9.9E-5	9900	1.0E-6	0.0001	1.0E-6	7064	0.0001	CS
156	-0.0434	-99.7701149425	0.0435	0.049	1.0E-6	17645	0.01931538	CS
260	-0.0116	-99.1452991453	0.0117	0.47	1.0E-6	79222	0.05796908	CS

GTHR - Frequently Asked Questions (FAQ)

What is the current GeneThera (CE) share price?

The current share price of GeneThera (CE) is US$ 0,0001

What is the 1 year trading range for GeneThera (CE) share price?

GeneThera (CE) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
STTOSITO Mobile Ltd (CE)	US$ 0,02 (1 999 900,00%)	278
NLVVFNew Leaf Ventures (CE)	US$ 0,0089 (889 900,00%)	6,92k
AAGRAfrican Agriculture Holdings Inc (CE)	US$ 0,008 (799 900,00%)	101
ETBIEastgate Biotech Corporation (CE)	US$ 0,0045 (449 900,00%)	2k
VWESQVintage Wine Estates Inc (CE)	US$ 0,002 (199 900,00%)	3,44k
NEXINexImmune Inc (CE)	US$ 0,0001 (-99,90%)	13,59k
JERTQJER Investors Trust Inc New (CE)	US$ 0,000001 (-99,67%)	10k
AGILQAgileThought Inc (CE)	US$ 0,0001 (-99,10%)	4,7k
GAYGFMontauk Metals Inc (PK)	US$ 0,0012 (-99,08%)	6,25k
IONMAssure Holdings Corporation (CE)	US$ 0,000001 (-99,00%)	112
HMBLHUMBL Inc (PK)	US$ 0,0005 (25,00%)	279,83M
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0,0026 (-3,70%)	123,47M
SPQSSportsQuest Inc (PK)	US$ 0,0001 (-50,00%)	114,57M
BOMObowmo Inc (PK)	US$ 0,0001 (0,00%)	102,85M
VTXBVortex Brands Company (PK)	US$ 0,0001 (0,00%)	101,18M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GeneThera Inc (CE) (GTHR)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

GTHR Dernières nouvelles

Applied Genetics Initiates Commercial Operation

Applied Genetics Signs Agreement With The National University Of Mexico (UNAM)

Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada

GeneThera, Inc. Acquires Applied Genetics, S.A.

GeneThera Extends its Reach Overseas

[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR

GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.

GeneThera Releases Results From Initial Animal Tests of E.Coli O157:h7 Vaccine Amid News of Increase of E.Coli Discoveries in Be

[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR

GeneThera - CHANGING DIRECTIONS - an Update to Shareholders

GTHR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

GeneThera Inc (CE) (GTHR) Cours

GeneThera Inc (CE) (GTHR)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

GTHR Dernières nouvelles

Applied Genetics Initiates Commercial Operation

Applied Genetics Signs Agreement With The National University Of Mexico (UNAM)

Applied Genetics Signs Marketing and Sales Agreement with Nutricion Avanzada

GeneThera, Inc. Acquires Applied Genetics, S.A.

GeneThera Extends its Reach Overseas

[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR

GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.

GeneThera Releases Results From Initial Animal Tests of E.Coli O157:h7 Vaccine Amid News of Increase of E.Coli Discoveries in Be

[video] Wall St. Network's 3-Minute Press Show Features Executive Interviews and Highlights Recent Press for the Following: GTHR

GeneThera - CHANGING DIRECTIONS - an Update to Shareholders

GTHR - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités